Dianthus Therapeutics, Inc.

DNTH· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$82.25-0.16%

2026-11-02

Financials

Valuation Metrics

Dianthus Therapeutics, Inc.'s Market Cap is $4.60B. At end of 2025 it was $1.56B. Ranked #1400 of 3,116 in US market (top 45%), #478 of 1,472 on NASDAQ (top 32%), #80 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 30%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$4.60B	US#1,400/3,116 Sec#80/265
Revenue	$2M	US#2,837/3,116 Sec#185/265
Net Income	$-30M	US—/3,116 Sec—/265
Total Assets	$1.21B	US#2,379/3,116 Sec#85/265
Net Assets	$1.17B	US#1,657/3,116 Sec#56/265
Value
P/B	3.93x	US#2,029/3,116 Sec#123/265
P/S	2259.63x	US#2,987/3,116 Sec#200/265
FCF Yield	-3.38%	US—/3,116 Sec—/265
Profitability
ROE	-2.55%	US#2,188/3,116 Sec#70/265
ROA	-2.47%	US#2,402/3,116 Sec#80/265
Op. Margin	-11441.39%	US#2,844/3,116 Sec#185/265
Revenue Growth	-60.77%	US#2,699/3,116 Sec#160/265
Financial Health
Debt Ratio	3.52%	US#29/3,116 Sec#7/265
Total Debt	$1M	US#2,961/3,116 Sec#239/265
FCF	$-156M	US#2,725/3,116 Sec#181/265
Cash	$111M	US#2,165/3,116 Sec#165/265
Current Ratio	26.10x	US#90/3,116 Sec#14/265
Performance
1Y Return	135.13%	US#68/3,116 Sec#23/265
1M Return	-6.76%	US#2,302/3,116 Sec#164/265
From 52W High	-30.23%	US#1,992/3,116 Sec#132/265
1Y MDD	-37.83%	US#1,811/3,116 Sec#104/265
Trading
Volume	558,561 shares	US#1,937/3,116 Sec#194/265
Trading Value	$46M	US#1,325/3,116 Sec#96/265
Per Share
EPS	$-0.53	US—/3,116 Sec—/265
BPS	$20.95	US#1,190/3,116 Sec#27/265